An interventional study of Volunteer visits in Dementia and Alzheimer's Disease, sponsored by Queen's University. Completed at 1 site in Canada. Open to participants aged 65 Years and older. Per ClinicalTrials.gov, last updated 2017-04-14.
Sponsored by Queen's University · Not applicable, Interventional, and Health services research
Older adults with Alzheimer's disease and other forms of dementia frequently develop challenging neuropsychiatric symptoms (NPS) as a result of their illness. Non-pharmacological strategies to manage these symptoms such as music, exercise, and participating in pleasant social events have been demonstrated to be safe and effective strategies to reduce these behavioral symptoms. Our project, Volunteers Adding Life in Dementia (VALID), will design and implement a volunteer-led program to reduce behavioral symptoms and improve the quality of life of older adults with dementia who are residing in long-term care facilities.
The number of older adults with Alzheimer's disease (AD) and related forms of dementia is increasing in Canada and the majority of individuals with dementia develop neuropsychiatric symptoms (NPS) such as agitation, psychosis, depression and anxiety at some time during their illness. NPS are particularly problematic in long-term care (LTC) where approximately 60% of individuals have dementia, and 80% of individuals with dementia have NPS at any time. Adverse outcomes associated with NPS include increased use of psychotropic medications, stress for families and nursing staff, increased costs of care, and decreased quality of life. A novel approach to implementing non-pharmacological interventions for LTC residents with NPS is the use of volunteers. Volunteer-led programs have been demonstrated to be an effective, inexpensive, and sustainable method of implementing psychosocial interventions for older adults in acute care. The objectives of our project are to: 1.) Recruit and train approximately 40 volunteers in the VALID program; 2.) Conduct a cluster-randomized controlled trial of the VALID program in 6 LTC facilities (3 intervention and 3 control LTC sites; 60 individuals with dementia in each of the experimental and control arms) to determine the effect of the VALID program on symptoms of NPS, patient quality of life, volunteer's experience, and LTC staff stress, 3.) Determine key components of the VALID program that served as facilitators and barriers to implementation.
3,678 studies on the registry are indexed under Alzheimer Disease; 872 are open to participants now.
This study's enrollment of 75 is close to the median of 70 across 2,808 interventional studies indexed under Alzheimer Disease.
Browse Alzheimer Disease studies →Queen's University is the lead sponsor of 199 studies on the registry; 16 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Individuals will receive usual care
Volunteers will visit 3 times per week with a visit duration of 30 minutes for each visit during the study.
Other: Volunteer visits
Volunteers will visit 3 times per week with a visit duration of 30 minutes for each visit during the study.
Change in neuropsychiatric symptoms (measured by the Cohen-Mansfield Agitation Inventory)
Time frame: Baseline, weeks 2,4,6,8 and 12
Change in Neuropsychiatric Inventory score
Time frame: Baseline, weeks 4, 8, 12
Change in Cornell Depression in Dementia Rating Scale score
Time frame: Baseline, weeks 4, 8, 12
Change in Dementia Quality of Life Scale (DEMQoL) score
Time frame: Baseline, weeks 4, 8, 12
Change in Clinical Global Impression of Change (CGI-C)score
Time frame: 12 weeks
Modified nursing care assessment scale (M-NACS)
Time frame: Baseline, week 12
Short Form Health Survey
Assessment of volunteer quality of life
Time frame: Baseline, week 12
This study is completed, as verified in Apr 2017. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Queen's University